Canopy Growth Corporation (CGC) AI Stock Analysis

Canopy Growth Corporation specializes in the cultivation, distribution, and retail of cannabis and hemp-based products for recreational and medical use, focusing primarily on Canada, the United States, and Germany. The business operates through two primary segments: Global Cannabis and Other Consumer Products. Its product catalog spans dried cannabis flower, extracts, concentrates, beverages, edibles including gummies, and vaporizers. Canopy Growth markets these products through brands such as Tweed, 7ACRES, DOJA, Martha Stewart CBD, BioSteel, and Tokyo Smoke. Headquartered in Smiths Falls, Canada, the company was originally founded in 2009 as Tweed Marijuana Inc. before rebranding in 2015.

Canopy Growth experienced a 5-year revenue compound annual growth rate of -12.2% from FY2021 to FY2026. Annual revenue dropped from $475.7M in FY2022 to $269.0M in FY2025 before increasing 5.8% to $284.6M in FY2026. Gross margin turned positive from -39.4% in FY2022 to 24.5% in FY2026, though operating margin remained negative at -25.7%. Net losses decreased from -$3.28B in FY2023 to -$262.9M in FY2026. For the latest quarter ending June 30, 2026, quarterly revenue grew 12.5% year-over-year, while trailing twelve months revenue stood at $293.6M with a profit margin of -79.2% and an operating margin of -21.7%.

As of June 30, 2026, Canopy Growth held $341.7M in cash and short-term investments alongside total debt of $277.3M, leaving net cash of $64.4M. Shareholders' equity was $688.6M against total assets of $1.10B, resulting in a debt-to-equity ratio of 0.40 and a current ratio of 3.04. Free cash flow improved from -$593.9M in FY2022 to -$69.8M in FY2026. In FY2026, capital expenditures were $6.0M, while the share count increased 7.2% over a five-year period.

Canopy Growth trades at a forward P/E of 20.4x, which stands above the 17.3x median of its US-listed Healthcare peers. Its price-to-sales multiple of 1.1x and price-to-book multiple of 0.8x sit below the sector peer median price-to-sales of 4.1x. The company's enterprise value is $363.8M relative to a market capitalization of $320.4M, with an EV to revenue multiple of 1.7x. Over the past year, the stock fell 47.2% compared to a 16.8% gain for the S&P 500, while over five years the stock is down 99.5% versus an 83.0% gain for the S&P 500.

Wall Street coverage includes 2 Strong Buy and 6 Hold recommendations, with zero Sell or Strong Sell ratings. The mean price target of $1.20 suggests a potential upside of 68.7% over the last close of $0.71. For the current fiscal year ending March 31, 2027, consensus estimates model an EPS of -$0.07 on revenue of $351.9M. For the following fiscal year, 1 analyst estimates revenue of $378.6M and an EPS of -$0.17. Canopy Growth beat EPS expectations in 2 of the past 4 quarters, and its next earnings date is scheduled for November 6, 2026.

This page is an AI-written research summary of Canopy Growth Corporation (CGC). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CGC income statement, CGC balance sheet, CGC key metrics, CGC analyst forecast, CGC chart. See the CGC stock overview for the latest quote and news.